Value of Arrival Metaphylaxis in U.S. Cattle Industry by Dennis, Elliott J. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Faculty Publications: Agricultural Economics Agricultural Economics Department 
2018 
Value of Arrival Metaphylaxis in U.S. Cattle Industry 
Elliott J. Dennis 
Kansas State University, elliott.dennis@unl.edu 
Ted C. Schroeder 
Kansas State University, tcs@k-state.edu 
David G. Renter 
Kansas State University, drenter@vet.ksu.edu 
Dustin L. Pendell 
Kansas State University 
Follow this and additional works at: https://digitalcommons.unl.edu/ageconfacpub 
Dennis, Elliott J.; Schroeder, Ted C.; Renter, David G.; and Pendell, Dustin L., "Value of Arrival Metaphylaxis 
in U.S. Cattle Industry" (2018). Faculty Publications: Agricultural Economics. 181. 
https://digitalcommons.unl.edu/ageconfacpub/181 
This Article is brought to you for free and open access by the Agricultural Economics Department at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications: 
Agricultural Economics by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Journal of Agricultural and Resource Economics 43(2):233–250 ISSN 1068-5502
Copyright 2018 Western Agricultural Economics Association
Value of Arrival Metaphylaxis in U.S. Cattle Industry
Elliott J. Dennis, Ted C. Schroeder, David G. Renter, and Dustin L. Pendell
Although several studies have estimated economic impacts of antimicrobials for growth
promotion, little is known about economic impacts of the common animal health management
strategy known as metaphylaxis: administering antimicrobials to groups of animals to prevent
disease. This article develops a new framework to map animal disease to producer profitability
and determine societal economic impacts surrounding metaphylactic use of antimicrobials in beef
cattle production. Results indicate the direct net return value of metaphylaxis to the U.S. fed cattle
industry is at least $532 million. Beef producer surplus losses of $1.8 billion would be associated
with eliminating metaphylaxis.
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Introduction
Use of antimicrobials in livestock production is facing intense public scrutiny. Although most
consumers agree that medicating sick animals is appropriate, opinions diverge on acceptable
use of antimicrobials administered to food-producing livestock (Landers et al., 2012). Producers
use antimicrobials to kill or inhibit the growth of bacteria that damage health, production
efficiency, and welfare of livestock (Key and McBride, 2014). Public concern over use of shared-
class antimicrobials in animal feeding operations, antimicrobial resistant bacteria, and potential
antimicrobial residuals in meat has escalated in recent years.1 Major restaurants, food service
companies, food processors, and supermarkets have pledged to reduce or eliminate antimicrobial
use in meat production (Pew Charitable Trusts, 2016). Federal and international organizations have
expressed growing concerns that the use of shared-class antimicrobials in livestock production for
growth promotion2 and disease prevention is linked to increased health risks and antimicrobial
resistance in humans (Centers for Disease Control and Prevention, 2013; World Health Organization,
2012).
Medical and disease-monitoring organizations have claimed that inappropriate use of shared-
class antimicrobials is occurring in livestock production. These groups have urged the U.S. Congress
to take action, stating “the misuse of important antibiotics in food animals must end, in order to
protect human health” (Pew Health Group, 2011, p. 3). These concerns, in part, have prompted state
and federal legislators to increase regulation and veterinary oversight of shared-class antimicrobials
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in animal production (American Veterinary Medical Association, 2016; California Legislature,
2015; Food and Drug Administration, 2012, 2013; Maryland Legislature, 2017).
Metaphylaxis is an animal health management practice that administers FDA-approved
antimicrobials, generally via injection, to groups of high-risk animals in order to eliminate or
minimize acute onset of a disease (U.S. Department of Agriculture, 2013). Cattle producers
selectively use this tool to reduce beef cattle health risks when cattle first arrive at feeding facilities
and occasionally during feeding. While scientific evidence linking metaphylaxis use in animal
production to negative impacts on human health is sparse, the European Union (2015) has explicitly
announced an EU-wide strategy to minimize metaphylaxis as a health treatment protocol in livestock
production. The World Health Organization (2017) has strongly recommended an overall reduction
in the use of shared-class antimicrobials for disease prevention without individual animal diagnosis
The U.S. Veterinary Feed Directive (VFD) regulation does not regulate metaphylaxis; current debate
centers on whether to include metaphylaxis in future U.S. regulation. Since metaphylaxis reduces
bovine respiratory disease (O’Connor et al., 2013; Abell et al., 2017), the most common cause
of morbidity and mortality in beef cattle, livestock producers are concerned that removing such a
widely used production technology would be detrimental to animal health and result in substantial
animal deaths, reduced animal welfare, increased production risk, and reduced profitability (Fears,
2015).
We estimate the value of metaphylactic use in U.S. cattle feeding and determine implications
for consumer and producer surplus of eliminating its use. Determining net return and social surplus
impacts enables producers, animal health consultants, and policy makers to make informed decisions
surrounding metaphylaxis use. Assessing policy options surrounding antimicrobial use in livestock
requires predicting animal health impacts, quantifying uncertainty, and determining distributional
impacts of net returns. The resulting estimates address this need by quantifying the impact of a
hypothetical policy prohibiting metaphylaxis use or voluntary elimination by the cattle industry.
Net return impacts of alternative animal health treatment strategies have not been adequately
quantified due to limited access to representative livestock feeding data. This article presents a
fed cattle industry simulation model developed to estimate net returns under alternative market
conditions, policies, and animal production technologies. Using 20 years of proprietary data from
10 large commercial Midwestern feedlots, we obtain short-run estimates of the effect of banning
the use of metaphylaxis upon arrival in the feedyard on cattle feeding profitability and producer
and consumer surplus. The fed cattle simulation incorporates veterinary costs associated with
metaphylaxis, changes in cattle performance parameters, and mortality distributions conditioned
on metaphylaxis use. The simulation estimates producer net returns across livestock placement
categories and treatment groups. Results from the cattle return simulation are used to estimate
changes in producer and consumer surplus at major market levels to determine economic impacts of
eliminating metaphylaxis.
Several studies have estimated the economic impacts of banning antimicrobials in livestock
production used in feed and water (Hayes et al., 2001; Brorsen et al., 2002; Miller et al., 2005;
MacDonald and Wang, 2011; Key and McBride, 2014). In contrast, little economic research
has evaluated metaphylactic antimicrobial use in animal production. Antimicrobial use in feed
and water and the health management practice of metaphylaxis have distinct purposes, uses,
animal outcomes, and producer profitability. Antimicrobials administered in feed and water balance
beneficial and harmful bacteria to improve nutrition and create homogeneous animal populations
(Cromwell, 2002). Antimicrobials administered during metaphylactic treatment strive to reduce
clinical and subclinical morbidity and mortality caused by actual or prospective illness. While both
are production technologies used to manage animal health, antimicrobials in feed and water are often
used to increase animal efficiency, whereas metaphylaxis specifically treats groups of animals with
elevated health risk. This important distinction requires a new framework to map animal disease
and health treatment strategies to producer profitability and estimate societal economic impacts
surrounding metaphylactic use in beef cattle production.
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Metaphylaxis Use in U.S. Cattle Feeding
Metaphylactic intervention reduces mortality and morbidity risk, may reduce medication costs,
reduces days on feed, and can improve carcass and offal quality (Schumann, Janzen, and McKinnon,
1990, 1991; Van Donkersgoed, 1992; Duff et al., 2000; Encinias et al., 2006; Cernicchiaro et al.,
2012; Tennant et al., 2014). Metaphylaxis is used to reduce the risk or impacts of an outbreak
of bovine respiratory disease (BRD), the most common cause of morbidity and mortality in U.S.
beef cattle production, affecting 97% of feedlots, 16% of cattle, and costing the beef industry an
estimated $6 billion annually (Griffin, 1997; U.S. Department of Agriculture, 2013). Metaphylaxis is
selectively used by 59% of U.S. feedlots on 20.5% of cattle placed on feed across all cattle placement
weights (U.S. Department of Agriculture, 2013).
The primary health management alternative to metaphylaxis is to only treat clinically observed
sick animals, commonly referred to as “pull-and-treat.” Compared to metaphylaxis, targeted pulling
and treating animals is costlier for feedlots to use on cattle where disease risk is high. Metaphylaxis
and pull-and-treat are commonly used jointly to manage high-health-risk cattle. However, as the
number of times an animal is pulled and treated increases, medication costs rise, carcass and offal
quality decline, and mortality and culling rates increase (Babcock et al., 2009; Cernicchiaro et al.,
2013). Hence, pull-and-treat is rarely used as the primary approach for high-health-risk cattle, which
are often more effectively managed using metaphylaxis followed by selective pull-and-treat.
The use of injectable antimicrobials, to which the metaphylaxis protocol is a major contributor,
accounted for 4% of total U.S. antimicrobial sales and distribution for livestock and other animals
(Food and Drug Administration, 2016). Use of antimicrobials in feed and water, to which the
metaphylaxis protocol is a minor contributor, is much more prevalent, account for 74% and 22%
of total sales, respectively. However, no data exist to quantify the use of antimicrobials in livestock
production, and sales data likely overestimate administration in a given time period.
Impact assessments have primarily focused on removing the larger relative proportion of
antimicrobials in feed and water for hogs, broilers, and cattle. Recent consumer surplus estimates
reflect relatively modest short-run losses associated with fully banning antimicrobials in feed and
water: $885.64 million for beef (Mathews, 2002), $41.87 million to $209.14 million for pork (Wade
and Barkley, 1992; Brorsen et al., 2002), and $235.47 million for broilers (Sneeringer et al., 2015).
Reductions in producer surplus are likewise small: $280.55 million for beef (Mathews, 2002),
between $45.36 million and $291.24 million for pork (Wade and Barkley, 1992; Brorsen et al.,
2002; Sneeringer et al., 2015), and $189 million for poultry (Sneeringer et al., 2015).3 However,
since metaphylaxis impacts cattle performance parameters and reduces mortality and morbidity as
well, producer and consumer surplus losses are likely more pronounced. To our knowledge, no
prior research has estimated the value of metaphylaxis on the beef cattle sector and its associated
economic surplus impacts on society.
Cattle Procurement and Metaphylaxis Decision
Cattle feeders make trade-offs when searching for cattle that will perform well in feedlot
environments. General cattle characteristics—including animal gender, origin, weight, condition,
and perhaps health background—are known to feedlots upon purchase. Feedlots make feeder cattle
purchase decisions based on feeder cattle supplies, feed costs, and season and adjust their cattle price
offers in accordance with perceived animal health risk. Prospective buyers categorize cattle into
economic risk groups conditional on expected mortality risk, cattle performance and characteristics,
feeding location, and time of year. Higher transaction prices are generally associated with healthier
animals with lower probabilities of morbidity and mortality. Low- and high-health-risk cattle are
often simultaneously available for purchase across different weight classes.
3 All values have been adjusted to 2017 price levels.
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Producers mitigate health risk in high-health-risk cattle through health management practices
such as metaphylaxis. Animal health-risk assessment for cattle purchased by feedlots is based on
cattle weight and age, whether cattle have been comingled from multiple sources, distance cattle
traveled prior to placement, season, and prior health treatments that may have been administered. In
this study, we define high-risk cattle as those entering the feedlot where metaphylaxis was used as
the initial health management practice (U.S. Department of Agriculture, 2013).
Mortality in cattle feeding is directly observed ex post and constitutes the largest observed health-
risk cost outcome. Death loss in feedlots is conditional on cattle health-risk category and animal
placement weight and can be modified with health management practices. Mortality distributions
are generally observed to be right-skewed with long tails, approximated using a log-normal, (zero-
inflated) negative binomial or a (zero-inflated) Poisson distribution and conditioned by placement
risk category, weight, season, gender, location, and breed (Babcock, 2010). Mortality data used in
this article follow a log-normal distribution but can also be adequately modeled using a gamma
distribution.
Metaphylaxis is effective in helping reduce feedlot mortality, but efficacy varies by drug,
placement weight, location, season, and animal health risk. In randomized-control studies testing
the effectiveness of metaphylaxis, using the commonly administered macrolide called Tilmicosin on
high-health-risk cattle, mortality has varied considerably across treatment and control groups. For
example, in control studies of metaphylaxis, Vogel et al. (1998) realized death losses of 1.65% in
the treatment group and 4.18% in the control group; Corbin et al. (2009) found 7.50% treatment,
13.50% control; and Tennant et al. (2014) observed 1.40% treatment, 3.07% control.4 In a recent
meta-analysis, Abell et al. (2017) reviewed 29 randomized-control trial studies of metaphylaxis use
in cattle and estimated odds ratios for various types of metaphylactic drugs. Odds ratio estimates
were weighted by U.S. Department of Agriculture (2013) metaphylaxis drug application rates for
two commonly used macrolides, Tilmicosin and Tulathromycin, to obtain industry efficacy rates.
On average, not administering metaphylaxis to high-risk cattle increased mean mortality (standard
deviation) 2.43 (5.57) times. While expected mortality distribution of a group of cattle may be
approximated, exact mortality risk present at cattle purchase and subsequently modified through
a health management practice is only realized after feeding.
Cattle experience varying degrees of morbidity due to stress of transport, weather, diet, and
comingling with other cattle (Nickell and White, 2010). Historical data on morbidity are not
generally available in cattle feedlot data but are discernible in readily available animal performance
data. Higher levels of morbidity are associated with lower average daily gain, increased veterinary
costs, more frequent lung lesions, less efficient feed conversion, lower offal quality, and poorer
meat quality grade (Cernicchiaro et al., 2012; Tennant et al., 2014). Health interventions in arriving
animals can reduce the risk of high levels of morbidity during the feeding period.
The general state of morbidity is associated with cattle gender, breed, arrival weight, location,
health treatment, arrival month, risk classification, pen size, feedlot size, and animal handling
practices. The hierarchical structure of cattle feedlot performance and cost data consists of cohorts
of cattle nested within feedlots. Random effects for feedlots and pen size can be used to model
animal performance determinants and account for clustering at the feedlot level and animal
management practices that differ across feedlots. The impact of other observable feedlot and cattle
characteristics—such as breed, arrival weight, and health treatment practice—on animal feeding
performance is captured through fixed effects. For example, effects of morbidity during feeding can
be modeled by changes in animal productivity measures of average daily gain, feed conversion, and
veterinary costs. Multivariate Tobit, ordinary least squares, and maximum likelihood have been used
to model changes in average daily gain, veterinary costs, and feed conversion in cattle (Miller et al.,
2005; Irsik et al., 2006; Belasco, 2008; Belasco et al., 2009).
4 Individual randomized controlled trials are limited in their ability to generalize the magnitude of reduction in mortality
associated with metaphylaxis treatments, particularly across season and weights, due to experimental design costs and small
sample sizes.
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Figure 1. Mortality Distributions across Cattle Placement Weight Categories and
Metaphylaxis Use Category
Notes: Normal mean and standard deviation mortality parameters for metaphylaxis and no metaphylaxis, respectively, are: i)
850 lb. (2.7, 1.3), (6.7, 7.2); ii) 700 lb. (4.5, 1.7), (11.0, 9.3); and iii) 550 lb. (5.0, 3.5) (12.3, 19.6).
Cattle Feeding Simulation Model
A cattle feeding simulation model is developed to incorporate how metaphylaxis conditions
cattle morbidity and mortality. Variation in cattle morbidity and mortality influences net return
distributions under alternative health management scenarios for heterogeneous at-risk fed cattle.
The cattle feeding simulation estimates changes in net returns distributions for cattle sold on a live-
weight basis. Net returns from cattle feeding are translated into short-run producer and consumer
surplus changes with and without the use of metaphylaxis in treatment of high-health-risk cattle.
Simulation Framework
Producers select a vector of cattle characteristics (α ) that includes gender, placement weight, and
expected harvest weight. In the simulation, feedlots purchase cattle from three different weight
categories (w) where w= calves (550 lb.), middle-weights (700 lb.), or yearlings (850 lb.).5 Once
cattle are purchased, α is fixed and cattle are categorized as either low or high health risk. Low-
health-risk cattle have low production and mortality risks and are never prescribed metaphylaxis but
are individually treated when clinical signs of morbidity are manifest (i.e., pull-and-treat). High-
health-risk cattle are prescribed metaphylaxis upon arrival at the feedlot and individually treated for
clinical signs of morbidity and mortality.
Producers, with veterinarian oversight, select a health management strategy (τ) that maximizes
expected animal well-being, performance, and ultimately profit. Given α , w, and τ , a producer
faces a random cattle death loss (ϕw,τ ). The primary driver of feedlot profitability in our simulator
is cattle mortality (MORT ). We calibrate a unique lognormal death-loss distribution, based on
Babcock (2010), for each of the six weight-by-treatment high-health-risk cattle groups: three cattle
types (550 lb., 700 lb., and 850 lb. placement weights) and two health treatments (metaphylaxis
or no metaphylaxis). Mortality distributions for high-health-risk cattle treated with metaphylaxis
were estimated using feedlot data. Mortality distributions for high-health-risk cattle not treated with
5 Younger cattle have less-developed immune systems and are more susceptible to infection and disease. Few cattle
purchased in the United States have a verified age. The weight categories selected reflect cattle purchase weights commonly
used by producers.
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Table 1. Feedlot Performance Summary Characteristics for Periods 1 and 2
January 1989–December 2008 Mean Std. Dev Min Max
Feed conversion (lb. feed/lb. gain) 6.07 0.59 3.01 9.91
Average daily gain (lb. gain/day) 2.96 0.56 1.51 5.98
Mortality (%) 1.24 1.76 0.00 25.64
Placement weight (lb.) 683.7 128.99 304.20 1,100.00
Days on feed (days) 154.5 44.17 128.00 229.00
Gender Steer 46% Heifer 54%
Season Spring 25.1% Summer 27.4%
Fall 24.3% Winter 23.2%
August 2014–December 2015 Mean Std. Dev Min Max
Feed conversion (lb. feed/lb. gain) 6.14 0.58 4.29 8.76
Average daily gain (lb. gain/day) 3.24 0.49 1.65 5.18
Mortality (%) 2.54 3.19 0.00 26.78
Placement weight (lb.) 700.8 177.49 301.00 1096.00
Days on feed (days) 192.8 67.20 87.00 443.30
Gender Steer 55% Heifer 45%
Season Spring 25.8% Summer 23.2%
Fall 25.8% Winter 25.2%
Notes: N = 48,341 for period 1. N = 1,321 for period 2.
metaphylaxis were based on estimates from Abell et al. (2017).6 Figure 1 displays the distributional
assumptions and generated mortality distributions across cattle types and health treatments (ϕw,τ ).
In feedlot data, performance parameters for cattle are measured for aggregate groups of animals
that either live and are marketed as fed cattle at harvest or die during feeding. As mortality rates
increase, pen performance parameters become skewed downward, often to irrational values. To
overcome this, net returns are calculated for k = {dead, alive} broad groups of cattle purchased by
producers: i) animals that survive feeding and sold and ii) animals that die. Given α , the kth group
death loss assumption, and a vector (γ k) of expected values, we calculate three cattle performance
parameters (ADG, AFC, and HC) using proprietary feedlot data. ADG is the average weight (in
lb.) gained during the feeding period, AFC is the average amount of feed (in lb.) consumed for an
additional pound of weight gain, and HC is health costs associated with feeding.
Proprietary data were collected from 10 large commercial feedlot operations located in
Midwestern states. The datasets encompass two periods: 1989–2008 and 2014–2015. The first
period comprises 48,341 pens of cattle (about 6 million head) over 20 years. Period 2 comprises
1,321 pens of cattle (about 264,000 head) over 1.5 years. Data for period 1 are typical feedlot
closeout data and are used to calibrate animal feeding performance (ADG and AFC) variation
conditioned on season, location, and animal weight. Health costs reported exclude arrival health
treatments, capturing only total animal health cost after feeding began; thus, health costs for this
dataset exclude possible costs associated with metaphylaxis. Data for period 2 contain similar animal
feedlot performance variables for the same companies but, because of the shorter period, are not
well suited for making inferences across time, season, and location. The data from period 2 detail
6 Since efficacy varies by drug type, death loss odds ratios reported by Abell et al. (2017) were adjusted to reflect the
percentage of cattle administered each type of metaphylatic drug (U.S. Department of Agriculture, 2013). Assuming drug
efficacy and treatment administration are constant across weight categories, we calculated a weighted mean and standard
deviation odds ratio. Taking the inverse of the odds ratio yields a normally distributed metaphylaxis efficacy multiplier.
Multiplying these by the observed feedlot mortality rates for each weight category treated with metaphylaxis provides a
normal mean and standard deviation for mortality.
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health costs documenting metaphylaxis use, individual animal costs associated with BRD, and their
impact on cattle performance, none of which are available in period 1. Specifically, the more recent
data enable us to identify costs associated with metaphylaxis in our cattle feeding risk simulation.
Table 1 displays summary statistics for the feedlot data.
Estimated Morbidity
Feedlot data quantify the impact of mortality on γ k in the simulation using linear mixed model
(LMM) regressions, which are commonly used in epidemiologic studies. Morbidity in cattle is not
directly observed in the data but manifests itself in lower ADG, increased AFC, and increased HC.
Estimated regressions relating these performance parameters to death loss are a combination of
pen- and feedlot-specific fixed effects and random effects from specific variables, including pen
size, breed, specific feedlot, year, placement weight, gender, and quarterly dummies. Specifically,
we estimate cattle performance parameters ADG and AFC using data from period 1 and associated
health costs (HC) using data from period 2 as follows (standard errors are in parentheses):
ADG = −4.056− 0.056 MORT + 1.086 lnPWT + 0.245 ST EER− 0.021 SPRING
(0.103) (0.001) (0.012) (0.004) (0.005)
(1)
− 0.102 SUMMER− 0.188 FALL
(0.005) (0.005)
AFC = −2.077 + 0.045 MORT + 1.262 lnPWT − 0.284 ST EER− 0.073 SPRING
(0.135) (0.001) (0.017) (0.005) (0.007)
(2)
− 0.302 SUMMER + 0.284 FALL
(0.007) (0.007)
HC = 30.515 + 1.606 MORT − 2.180 lnPWT + 23.811 METAPHY LAXIS
(3)
(7.909) (0.086) (1.152) (0.708)
where ADG, AFC, and HC are as previously specified, MORT is the proportion of animals in a
pen that died during the feeding period, and lnPWT is the natural log of weight of cattle upon
arrival at feedlot. Higher placement weights are associated with lower daily gains and higher feed
conversion. ST EER is a binary variable equal to 1 if group gender is a steer and 0 otherwise and
SPRING, SUMMER, and FALL are quarterly binary variables for placement on feed timing. Steers
are associated with higher daily gains and lower feed conversions.
METAPHY LAXIS is a binary variable equal to 1 if an animal was part of a pen of cattle
administered antimicrobials upon arrival at the feeding operation and 0 otherwise. If metaphylaxis is
used, a producer incurs an estimated $23.81/head, consistent with results from the National Animal
Health Monitoring Survey (NAHMS, U.S. Department of Agriculture, 2013) that reported costs of
$23.50/head to administer metaphylaxis to at-risk feeder cattle. In the simulation, MORT , lnPWT ,
and METAPHY LAXIS are varied, but we multiplied the proportion of steers placed on feed over the
past 10 years to obtain an average gender and multiplied the seasonal coefficients by the proportion
of cattle placed on feed over the last 10 years to obtain an average season. Thus, the simulation
effects are for the average gender over an average season.
The variables ADG, AFC, and HC are known to be correlated with each other and vary by risk
category and health intervention. To make these variables individually stochastic, yet correlated, we
model the joint distribution using Iman and Conover’s (1980) algorithm for 10,000 iterations. We
assumed cattle performance parameters (ADG, AFC, and HC) are distributed Nk ∼ (γ k,σ ), where
σ is a vector of variances from the estimated LMM residuals and γ k is the previously specified
estimates of ADG, AFC, and HC for the kth group, given a linear dependency structure. This
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produces simulated cattle parameters (ADG, AFC, and HC) with mean, variance, and dependency
structure of cattle performance variables identical to those observed in feedlot data.
Feeding Net Returns
We use simulated ADG, AFC, and HC values, random cattle death loss, fixed prices,7 and exogenous
feedlot characteristics to calculate cattle feeding net returns, ρw,k,τ , defined as
ρw,k,τ = T Rw,k,τ − F DRCw − YCw,k,τ − FCw,k,τ − HCw,τ − ICw,k,τ(4)
T Rw,k,τ = F P ×CSW k × (1− SHRINK)× (1−MORT w,k,τ −CU LL)
(5)
+ (CU LL ×CU LLW ×CU LLP)
F DRCw = F RPw ×CPW w(6)
YCw,k,τ = 0.30× DOF w,k,τ(7)
FCw,k,τ = F EED × {AFCw,k,τ [CSW w,k,τ × (1−MORT w,k,τ −CU LL)−CPW w]}(8)
ICw,k,τ = {0.5× [YCw,k,τ + FCw,k,τ + HCw,τ ] + F DRCw} × DOF w,k,τ × (IR/365).(9)
Table 2 displays and explains the simulated and fixed feeding net return variables used in
equations (4)–(9).
A weighted-average net returns of cattle feeding (piw,τ ) is recovered using the matrix of
calculated cattle feeding net returns (ρw,k,τ ) from equations (4)–(9). Given the stochastic mortality
(ϕw,τ ) and a representative pen size of 120 head, ϕw,τ × 120 number of net returns from the ρw,dead,τ
distribution are included while the remaining (1− ϕw,τ)× 120 cattle net returns are selected from
ρw,alive,τ . This is done 10,000 times, taking the mean of each iteration and thus obtaining a weighted-
average net return distribution (piw,τ ).
A weighted-average net return (piw,τ ) for each weight-by-treatment category, where w= (500,
700, or 850 pound placement weight) and τ = (metaphylaxis, no metaphylaxis) is used to calculate
the industry net return value of metaphylaxis and the value of metaphylaxis as a proportion of
industry gross revenue to high-risk cattle. The latter is calculated as
(10) ∅= ∑
3
w=1(vw × cw × xw)
ξ
,
where the value per head of health management strategy (νw) is obtained by taking the difference
in expected values from the health intervention (i.e., metaphylaxis). The number of cattle placed
on feed in a given year in each weight class is cw, xw is the proportion of cattle administered
metaphylaxis, and ξ is the fed cattle industry total revenue calculated as pounds produced multiplied
by dollars per pound for fed cattle.
Producer and Consumer Surplus Impact
A multimarket partial equilibrium that allows for shocks in the fed cattle industry to be transmitted
from beef to pork, lamb, and poultry is framed using an equilibrium displacement model (EDM).
The EDM is used to estimate changes in producer and consumer surplus that would be incurred by
fully eliminating the use of metaphylaxis in the fed cattle industry. EDMs have frequently been used
in the livestock and meat sector for determining the impacts of exogenous shocks along and across
marketing chains. Lusk and Anderson (2004) and Brester, Marsh, and Atwood (2004) used EDMs
7 To compare health interventions and cattle risk category, we calibrate feeder cattle prices so that the expected net returns
for metaphylaxis across risk categories are break even.
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Table 2. Feeding Net Return Variables
Variables Description Value/Calculation
Simulated
ADGw,k,τ Average daily gain during feeding (lb./head/day) See equation (1)
AFCw,k,τ Average pounds of feed consumed per pound of weight gain (lb. feed/lb. gain) See equation (2)
DOF w,k,τ Number of days on feed (days)
CSW w, k,τ−CPW w
ADGw, k,τ
FCw,k,τ Feed cost ($/head) See equation (8)
HCw,τ Animal health care cost including metaphylaxis, pull-and-treat, vaccinations,
labor costs, etc. ($/head)
See equation (3)
ICw,k,τ Interest cost ($/head) See equation (9)
MORT w,k,τ Proportion of death loss in purchased group ϕw,τ
T Rw,k,τ Total revenue from cattle sales ($/head) See equation (5)
YCw,k,τ Yardage cost of feeding cattle ($/head) See equation (7)
ρw,k,τ Net feeding returns ($/head) for each weight (w), death loss group (k), and
treatment (τ)
See equation (4)
Fixed
CPW w Cattle purchase weight (lb./head) 550, 700, 850
CSW k Finished animal weight (lb./head) if animal reaches maturity (i.e., k = alive), 0
otherwise (i.e., k = dead).
1,350
CU LL Proportion chronically ill animals culled from the remaining cohort 0.014
CU LLP Price received for culled animals ($/lb.) 0.75 × F P
CU LLW Average weight of culled animals (lb./head) 861
F DRCw Feeder cattle purchase cost ($/head) See equation (6)
F EED Corn price when cattle are placed on feed ($/lb.) 0.0923
F P Fed cattle sale price ($/lb.) 1.48
F RPw Purchase price for CPW 550, 700, and 850 lb. ($/lb.) 1.70, 1.49, 1.39
IR Annualized interest rate 0.05
SHRINK Proportion shrink in live weight when marketed 0.04
to estimate the effects of country-of-origin labeling on meat producers and consumers. Schroeder
and Tonsor (2011) constructed an EDM to estimate economic impacts of removing a cattle feeding
production technology. Pendell et al. (2013) employed an EDM to assess impacts of international
trade for requirements of cattle age and source verification.
The EDM we use in this study is an updated version of the multimarket partial equilibrium model
documented in Pendell et al. (2010). Market parameters—including supply, demand, and quantity
transmission elasticities as defined in Pendell et al. (2010)—were retained, with updates to selected
elasticity estimates (see online supplement).8 The EDM is composed of four sectors for the beef
and lamb industries: retail (consumers), wholesale (packers), fed (cattle/lamb feeding), and farm
(cow–calf/lamb producers). Pork and poultry markets are highly integrated and thus we model them
using three sectors: retail, wholesale, and producer. Each sector explicitly models international trade
at the wholesale sector. The base year price and quantity were updated to reflect 2015 prices and
quantities. Changes in consumer and producer surplus can be calculated from changes in prices and
quantities from the EDM model. Equation (10) represents the one-time, 1-year exogenous shock to
the fed cattle sector of removing metaphylaxis.
8 Demand elasticities were updated to reflect more current demand elasticity estimates. The updated elasticities used in
the EDM are retail beef −0.420 (Tonsor, Mintert, and Schroeder, 2010), fed cattle −0.66 (Marsh, 1992), feeder cattle −0.62
(Marsh, 2001), retail pork −0.7396 (Tonsor, Mintert, and Schroeder, 2010), and retail poultry −0.099 (Tonsor, Mintert, and
Schroeder, 2010).
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Figure 2. Simulated Net Return Distributions by Cattle Health Risk and Placement Weight
Notes: 550 lb. high-risk cattle lose $104.46/head relative to treated cattle, 700 lb. high-risk cattle lose $99.26/head, and 850
lb. high-risk cattle lose $63.36/head when not treated with metaphylaxis. Typical cattle feeding returns over a comparable
period across all placement weights were -$43.39/head (Focus on Feedlots, 2015).
Results
We selected feeder cattle prices to use in the simulation so that comparisons could be made across
treatment groups for each specific placement weight. For example, net returns for 550 lb. feeder
cattle can be compared with and without metaphylaxis administered. Figure 2 depicts the simulated
net returns of metaphylaxis use on high-risk cattle across the three placement weight categories.
Negative values indicate the losses conditioned by metaphylaxis treatment. All reported results are
on a per head live-weight basis for a weighted-average gender and season.
Overall, using metaphylaxis reduces mean occurrence and extreme death loss, resulting in
greater net returns with reduced variability. Metaphylaxis is most profitable when administered
to high-risk cattle with lighter placement weight. On average, high-risk 550 lb. placements lose
$104.46/head when not treated with metaphylaxis, high-risk 700 lb. cattle lose $99.26/head, and
high-risk 850 lb. cattle lose $63.36/head relative to treated cattle.
Impact of Removing Metaphylaxis
The percentage of cattle administered metaphylaxis and the number of cattle placed on feed by
weight category were used to translate the simulated return distributions into an industry-wide
valuation of metaphylaxis. The Livestock Marketing Information Center (2015) reports placements
of cattle by year and weight category from USDA data. Weight categories comparable to those used
in our simulation were obtained by aggregating cattle into three placement weight groups: 500–625
lb., 626–775 lb., and 776–925 lb. Roughly one-third of cattle placed on feed in 2015 were in each
calculated category with slightly more placements in heavier weights.
The NAHMS intermittently monitors and surveys health management practices in the cattle
industry. In 2011, feedlots with more than 1,000-head capacity reported metaphylaxis administration
rates of 2.81%, 18.01%, and 68.01% for 850 lb., 700 lb., and 550 lb. cattle placed on feed,
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respectively (U.S. Department of Agriculture, 2013).9 Using these assumptions and equation (10),
we calculated the value of metaphylaxis as a percentage of the U.S. fed cattle industry.
Table 3 summarizes the results. Metaphylaxis is worth $532.18 million to the cattle feeding
industry. That is, if metaphylaxis were eliminated in the feedlot sector, not allowing cattle producers
to substitute into other health management or procurement practices, net returns to the cattle feeding
sector would decline by $532.18 million annually, equivalent to a 0.92% reduction in gross feedlot
revenue.
Several important differences were revealed when comparing the percentage of cattle given
metaphylaxis reported by NAHMS in 2011 and proprietary feedlot health data from 10
large commercial Midwestern feedlots analyzed in 2014–2015 (period 2 data). Feedlot data
indicate metaphylaxis health management changes by weight category. Heavier-weight cattle are
administered metaphylaxis less often than lighter cattle. The proprietary feedlot data indicated
that metaphylaxis was administered to 86.85% of 550–625 lb. placements, 23.10% of 626–775 lb.
placements, 3.59% of 776–925 lb. placements, and 26.00% of all cattle placed. These estimates are
higher than those reported by NAHMS of 68.01%, 18.01%, 2.81%, and 20.50%, respectively, for
each of the three placement weight categories and overall cattle treatment. Using the more intense
metaphylaxis use from the feedlot data, we estimated an alternative value of metaphylaxis to the fed
cattle industry. If metaphylaxis were administered in the United States at the same rate as in our
feedlot sample, eliminating metaphylaxis would reduce net returns to the cattle feeding sector by
$679.56 million annually, equivalent to 1.17% of industry gross revenue (see Table 3).
Several limitations are important to mention before interpreting the reported estimated values of
metaphylaxis. First, the estimated valuation is likely an upper estimate because the simulation model
does not enable producers to switch to another health management strategy if metaphylaxis use were
eliminated. No substantial alternative presently exists that could effectively replace metaphylaxis,
so how much our estimate overstates the impact is debatable. However, it provides an estimate for
how much an alternative health management technology could cost and still incentivize producer
adoption. Short-term solutions would likely revolve around changes in cattle procurement strategies
by weight and season rather than switching to other technologies, which would imply that industry
losses would be similar to those estimated here but shifted upstream to feeder cattle suppliers.
Second, the net return simulation depends on calibrating the death-loss distributions, particularly
how they differ with and without metaphylaxis. No large-scale randomized trial of the impacts of
metaphylaxis (versus negative control cattle) exists. Our death loss distribution is calibrated from a
mixed treatment control meta-analysis that examined 29 randomized control studies, which are the
most reliable estimates available. In the following section, we evaluate how sensitive our results are
to this calibration.
Third, the percentage of cattle given metaphylaxis in each group affects the total value of the
health management strategy. Larger placements of 550 lb. animals increase the shock magnitude.
Fourth, fed and feeder cattle price levels impact the value of metaphylaxis. Higher fed cattle
prices create greater value associated with metaphylaxis, ceteris paribus; as cattle prices increase,
the cost of animal death loss increases. How much this affects our estimates is discussed in the
following section.
Fifth, metaphylaxis is only eliminated from cattle production. This implies pork and poultry
producers would not change antimicrobial use practices. This simplification allows us to obtain a
cattle-specific value of metaphylaxis without other compounding effects.
9 NAHMS categorized Central Region cattle given metaphylaxis as under 700 lb. (37.8%), greater than 700 lb. (4.8%),
and overall (20.5%). To obtain comparable cattle weight categories to our study, we calculated metaphylaxis administration
rates by scaling metaphylaxis rates from the feedlot data and then multiplying by the number of cattle placed in each group,
maintaining the group metaphylaxis administration rate of 20.5%.
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Sensitivity Analysis
The two important drivers of results in the simulation model are feeder and fed cattle prices and
the death loss distributions of fed cattle.10 The average fed cattle price used in this simulation was
$148/cwt (see Table 2). To illustrate the sensitivity of results to cattle prices, we compared results
with two different fed cattle prices, $171.00/cwt and $125.24/cwt, which correspond to high and low
prices observed between Fall 2011 and Fall 2017. These represent prices approximately 15% above
and below the base simulation price. Results reveal that, if cattle were prescribed metaphylaxis
at the rate specified by NAHMS, the net return value of metaphylaxis would be $639.83 million
(19.11% higher) if the fed cattle price were $171.00/cwt and $424.71 million (20.19% lower) with
$125.24/cwt. As such, fed cattle price has important impacts on the value of metaphylaxis because
higher fed cattle prices, ceteris paribus, are associated with higher feeder cattle prices and any death
loss has a greater economic cost.
The median odds ratio estimates proposed by Abell et al. (2017) were used to calibrate the death
loss distributions used in the base simulated model. The authors calculated 95% confidence intervals
for two common macrolides, Tilmicosin and Tulathromycin. Using this information, we estimated
death loss calibrations for the 2.5th and 97.5th percentiles. Results are sensitive to death loss
distributions. Given the metaphylaxis application rates reported by NAHMS, removing metaphylaxis
would result in feedlot net return losses of $91.01 million at the 2.5th percentile and $1,119.56
million at the 97.5th percentile.
Surplus Implications
We quantify short-run societal impacts of removing metaphylaxis. Table 4 presents surplus estimates
of a complete removal of metaphylaxis using both the NAHMS survey data and proprietary feedlot
data with the associated 0.92% and 1.17% losses in net returns to the cattle feeding industry.
Feedlots ultimately pass costs downstream to feeder cattle producers, resulting in higher losses in
the feeder cattle sector. Feedlots would lose from $924.86 million to $1,179.85 million, and feeder
cattle producers would lose $1,060.78 million to $1,354.22 million in producer surplus in year 1 if
metaphylaxis were eliminated. Higher beef retail prices induce consumers to substitute into other
meat products, leading to gains for pork, poultry, and lamb producers.
The wholesale beef market would lose $206.97 million to $267.45 million, while retailers would
experience a short-run surplus gain of $377.45 million to $476.70 million. Overall, beef producer
surplus would decline by $1,809.52 million to $2,322.44 million. Total consumer surplus would
decrease by $1,074.23 million to $1,370.51 million.
Conclusion
Antimicrobial use in livestock production is an increasingly important societal concern. All animal
drug use is regulated, and we will continue to see more stringent regulations—the VFD and state-
mandated antibiotic-use policies are recent examples. In addition, consumers and retailers are
becoming more health conscious, demanding more traceability, restrictive farming practices, and no
antibiotic use in meat production. These demands and policies will continue to increase costs while
offering minimal demand responses, thus reducing both consumer and producer welfare (Saitone,
Sexton, and Sumner, 2015).
10 Given the number of parameters fixed in equations (4)–(10), explained in Table 2, we also conducted sensitivity analyses
to determine how parameter choices influenced results. Changes in interest rate (IR), shrink (SHRINK), culling percent
(CULLP), culling weight (CULLW ), and yardage cost (YC) increase the size of the impacts by a nominal amount. Cattle
finished weight had a small impact. As finished weight increases to 1,500 lb./head, the net benefit of metaphylaxis increases
by $0.020/head/lb., $0.033/head/lb., and $0.046/head/lb. for cattle placed at 550 lb., 700 lb., and 850 lb., respectively. Overall,
the model is stable to the fixed parameters in the simulation.
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Table 4. Short-Run (1-Year) Producer and Consumer Surplus Estimates of Metaphylaxis
Elimination, 2015
Surplus Measure
NAHMSa
(million $)
Feedlot Data
(million $)
Producer surplus
Beef
Retail 377.45∗∗ 476.70∗∗
Wholesale −206.97∗∗ −267.45∗∗
Fed Cattle −924.86∗∗ −1,179.85∗∗
Feeder cattle −1,060.78∗∗ −1,354.22∗∗
Total beef producer surplus −1,809.52∗∗ −2,322.44∗∗
Pork
Retail 117.36∗∗ 149.88∗∗
Wholesale 38.84∗∗ 49.60∗∗
Fed hog 22.36∗∗ 28.56∗∗
Total pork producer surplus 183.03∗∗ 233.76∗∗
Lamb
Retail 1.55∗∗ 1.98∗∗
Wholesale 0.21∗∗ 0.27∗∗
Fed lamb 0.08∗∗ 0.11∗∗
Feeder lamb 0.07∗∗ 0.09∗∗
Total lamb producer surplus 1.93∗∗ 2.47∗∗
Poultry
Retail 570.41∗∗ 728.52∗∗
Wholesale 250.30∗∗ 319.65∗∗
Total poultry producer surplus 829.26∗∗ 1,059.14∗∗
Total meat producer surplus −772.53∗∗ −996.66∗∗
Consumer surplus
Retail
Beef −1,148.77∗∗ −1,465.37∗∗
Pork 58.54∗∗ 74.75∗∗
Domestic lamb −0.37∗∗ −0.47∗∗
Imported lamb 3.81∗∗ 4.86∗∗
Poultry 1.44∗∗ 1.80∗∗
Total meat consumer surplus −1,074.23∗∗ −1,370.51∗∗
Notes: Double asterisks (**) indicate significance at the 5% level. aNational Animal Health Monitoring Survey.
On the policy horizon is whether metaphylaxis, an integral animal health management strategy
administered to high-health-risk cattle upon arrival at feeding operations, should be more intensively
regulated or even eliminated as an animal health management option. To our knowledge, this study
is the first to estimate the value of metaphylaxis, an animal health treatment, in any livestock sector,
with particular focus on the U.S. beef cattle sector.
Metaphylaxis is uniquely suited to reduce mortality and morbidity in high-health-risk animals.
Using industry metaphylaxis data from the National Animal Health Monitoring System surveys
and proprietary feedlot production data, the net return value of metaphylaxis to the cattle feeding
industry is $532 million to $680 million per year. Eliminating metaphylaxis would reduce beef
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producer surplus by $1.81 billion to $2.32 billion and overall consumer surplus by $1.15 billion to
$1.47 billion per year.
Removing a production technology (such as metaphylaxis) that directly impacts animal mortality
risk is costlier than removing a production technology (such as antimicrobials in feed and water)
that targets production efficiency. Producer and consumer surplus estimates are larger in comparison
to studies that estimated short-run economic impacts of bans on antimicrobials in feed and water
($280.55 million for beef producers (Mathews, 2002), $45.36 million to $291.24 million for pork
producers (Wade and Barkley, 1992; Brorsen et al., 2002; Sneeringer et al., 2015), and $189.00
million for poultry producers (Sneeringer et al., 2015)).
The better we can predict animal health, quantify uncertainty, and determine net return
distributional impacts for antimicrobial use practices in cattle production, the more informed
specific policy options become. Results also inform industry stakeholders about how much
production/marketing practices would need to be offset if alternative treatments are developed. As
public scrutiny of antimicrobials used to treat at-risk animals in feeding operations escalates, a body
of research assessing economic and societal surplus impacts of eliminating metaphylaxis is essential
for making informed policy decisions.
[Received November 2017; final revision received March 2018.]
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Table S1. Elasticity Definitions, Estimates, and Sources for the Log Differential Equilibrium
Displacement Model
Definition
Estimated
Short Run Source
Own-price elasticity of demand for retail beef −0.42 Tonsor and Schroeder (2010)
Cross-price elasticity of demand for retail beef with respect
to the price of retail pork
0.10 Brester and Schroeder (1995)
Cross-price elasticity of demand for retail beef with respect
to the price of domestic retail lamb
0.05 Pendell et al. (2010) best estimate
Cross-price elasticity of demand for retail beef with respect
to the price of imported retail lamb
0.05 Pendell et al. (2010) best estimate
Cross-price elasticity of demand for retail beef with respect
to the price of retail poultry
0.05 Brester and Schroeder (1995)
Own-price elasticity of supply for retail beef 0.36 Brester, Marsh, and Atwood (2004)
Own-price elasticity of demand for wholesale beef −0.58 U.S. Department of Agriculture (2007a)
Own-price elasticity of supply for wholesale beef 0.28 Brester, Marsh, and Atwood (2004)
Own-price elasticity of demand for wholesale beef imports −0.58 Pendell et al. (2010) best estimate
Own-price elasticity of supply for wholesale beef imports 1.83 Estimated by Pendell et al. (2010)
Own-price elasticity of demand for wholesale beef exports −0.42 Zhao, Wahl, and Marsh (2006)
Own-price elasticity of demand for slaughter cattle −0.66 Marsh (1992)
Own-price elasticity of supply for slaughter cattle 0.26 Marsh (1994)
Own-price elasticity of demand for feeder cattle −0.62 Marsh (2001)
Own-price elasticity of supply for feeder cattle 0.22 Marsh (2003)
Own-price elasticity of demand for retail pork −0.74 Tonsor and Schroeder (2010)
Cross-price elasticity of demand for retail pork with respect
to the price of retail beef
0.18 Brester (1996)
Cross-price elasticity of demand for retail pork with respect
to the price of domestic retail lamb
0.02 Pendell et al. (2010) best estimate
Cross-price elasticity of demand for retail pork with respect
to the price of imported retail lamb
0.02 Pendell et al. (2010) best estimate
Cross-price elasticity of demand for retail pork with respect
to the price of retail poultry
0.02 Brester (1996)
Own-price elasticity of supply for retail pork 0.73 Brester, Marsh, and Atwood (2004)
Own-price elasticity of demand for wholesale pork −0.71 Brester, Marsh, and Atwood (2004)
Own-price elasticity of supply for wholesale pork 0.44 Brester, Marsh, and Atwood (2004)
Own-price elasticity of demand for wholesale pork imports −0.71 Pendell et al. (2010) best estimate
Own-price elasticity of supply for wholesale pork imports 1.41 Pendell et al. (2010) best estimate
Own-price elasticity of demand for wholesale pork exports −0.89 Paarlberg et al. (2008)
Own-price elasticity of demand for slaughter hogs −0.51 Wohlgenant (2005)
Own-price elasticity of supply for slaughter hogs 0.41 Lemieux and Wohlgenant (1989)
Own-price elasticity of demand for domestic retail lamb −0.52 U.S. Department of Agriculture (2007b)
Cross-price elasticity of demand for domestic retail lamb
with respect to the price of imported retail lamb
0.29 U.S. Department of Agriculture (2007b)
Cross-price elasticity of demand for domestic retail lamb
with respect to the price of retail beef
0.05 Pendell et al. (2010) best estimate
Cross-price elasticity of demand for domestic retail lamb
with respect to the price of retail pork
0.02 Pendell et al. (2010) best estimate
Cross-price elasticity of demand for domestic retail lamb
with respect to the price of retail poultry
0.02 Pendell et al. (2010) best estimate
Own-price elasticity of supply for domestic retail lamb 0.15 U.S. Department of Agriculture (2007b)
Own-price elasticity of demand for imported retail lamb −0.41 U.S. Department of Agriculture (2007b)
Cross-price elasticity of demand for imported retail lamb
with respect to the price of domestic retail lamb
0.78 U.S. Department of Agriculture (2007b)
Cross-price elasticity of demand for imported retail lamb
with respect to the price of retail beef
0.05 Pendell et al. (2010) best estimate
Cross-price elasticity of demand for imported retail lamb
with respect to the price of retail pork
0.02 Pendell et al. (2010) best estimate
Cross-price elasticity of demand for imported retail lamb
with respect to the price of retail poultry
0.02 Pendell et al. (2010) best estimate
Own-price elasticity of supply for imported retail lamb 10.00 U.S. Department of Agriculture (2007b)
Own-price elasticity of demand for wholesale lamb −0.35 U.S. Department of Agriculture (2007b)
Own-price elasticity of supply for wholesale lamb 0.16 U.S. Department of Agriculture (2007b)
Cross-price elasticity of demand for retail poultry with
respect to the price of domestic retail lamb
0.02 Pendell et al. (2010) best estimate
Cross-price elasticity of demand for retail poultry with
respect to the price of imported retail lamb
0.02 Pendell et al. (2010) best estimate
Own-price elasticity of demand for slaughter lamb −0.33 U.S. Department of Agriculture (2007b)
Own-price elasticity of supply for slaughter lamb 0.12 U.S. Department of Agriculture (2007b)
Own-price elasticity of demand for feeder lamb −0.11 U.S. Department of Agriculture (2007b)
Own-price elasticity of supply for feeder lamb 0.09 U.S. Department of Agriculture (2007b)
Own-price elasticity of demand for retail poultry 0.99 Tonsor and Schroeder (2010)
Cross-price elasticity of demand for retail poultry with
respect to the price of retail beef
0.18 Brester (1996)
Own-price elasticity of demand for retail poultry −0.29 Brester (1996)
Cross-price elasticity of demand for retail poultry with
respect to the price of retail beef
0.18 Brester (1996)
Cross-price elasticity of demand for retail poultry with
respect to the price of retail pork
0.04 Brester (1996)
Own-price elasticity of supply for retail poultry 0.18 Brester, Marsh, and Atwood (2004)
Own-price elasticity of demand for wholesale poultry −0.22 Brester, Marsh, and Atwood (2004)
Own-price elasticity of supply for wholesale poultry 0.14 Brester, Marsh, and Atwood (2004)
Own-price elasticity of demand for wholesale poultry exports −0.31 Estimated by Pendell et al. (2010)
Percentage change in retail beef supply given a 1% change in
wholesale beef supply
0.771 Estimated by Pendell et al. (2010)
Percentage change in wholesale beef demand given a 1%
change in retail beef demand
0.995 Estimated by Pendell et al. (2010)
Percentage change in wholesale beef supply given a 1%
change in slaughter cattle supply
0.909 Estimated by Pendell et al. (2010)
Percentage change in slaughter cattle demand given a 1%
change in wholesale beef demand
1.090 Estimated by Pendell et al. (2010)
Percentage change in slaughter cattle supply given a 1%
change in feeder cattle supply
1.070 Estimated by Pendell et al. (2010)
Percentage change in feeder cattle demand given a 1%
change in slaughter cattle demand
0.957 Estimated by Pendell et al. (2010)
Percentage change in retail pork supply given a 1% change in
wholesale pork supply
0.962 Estimated by Pendell et al. (2010)
Percentage change in wholesale pork demand given a 1%
change in retail pork demand
0.983 Estimated by Pendell et al. (2010)
Percentage change in wholesale pork supply given a 1%
change in slaughter hog supply
0.963 Estimated by Pendell et al. (2010)
Percentage change in slaughter hog demand given a 1%
change in wholesale pork demand
0.961 Estimated by Pendell et al. (2010)
Percentage change in retail domestic lamb supply given a 1%
change in wholesale lamb supply
0.908 Estimated by Pendell et al. (2010)
Percentage change in wholesale lamb demand given a 1%
change in retail domestic lamb demand
0.731 Estimated by Pendell et al. (2010)
Percentage change in slaughter lamb supply given a 1%
change in feeder lamb supply
0.864 Estimated by Pendell et al. (2010)
Percentage change in feeder lamb demand given a 1%
change in slaughter lamb demand
0.962 Estimated by Pendell et al. (2010)
Percentage change in retail poultry supply given a 1% change
in wholesale poultry supply
0.806 Estimated by Pendell et al. (2010)
Percentage change in wholesale poultry demand given a 1%
change in retail poultry demand
1.035 Estimated by Pendell et al. (2010)
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Table S2. Variable Definitions and Estimates for the Structural and Equilibrium
Displacement Models, 2015
Mean
Quantity of
Beef
Retail beef, billion lb. (retail weight) 17.40
Wholesale beef, billion lb. (carcass weight) 23.78
Wholesale beef imports, billion lb. (carcass weight) 3.37
Wholesale beef exports, billion lb. (carcass weight) 2.27
Beef obtained from slaughter cattle, billion lb. (live weight) 39.11
Beef obtained from feeder cattle, billion lb. (live weight) 34.30
Pork
Retail pork, billion lb. (retail weight) 15.94
Wholesale pork, billion lb. (carcass weight) 24.50
Wholesale pork imports, billion lb. (carcass weight) 1.12
Wholesale pork exports, billion lb. (carcass weight) 5.01
Pork obtained from slaughter hogs, billion lb. (live weight) 32.68
Lamb
Retail domestic lamb, billion lb. (retail weight) 0.13
Retail imported lamb, billion lb. (retail weight) 0.19
Wholesale lamb, billion lb. (carcass weight) 0.15
Lamb obtained from slaughter lamb, billion lb. (live weight) 0.30
Lamb obtained from feeder lamb, billion lb. (live weight) 0.26
Poultry
Retail poultry, billion lb. (retail weight) 33.56
Wholesale poultry, billion lb. (RTC) 46.20
Retail poultry exports, billion lb. (retail weight) 6.99
Price of
Beef
Choice retail beef, cents/lb. 628.89
Wholesale Choice beef, cents/lb. 237.48
Wholesale beef imports, cents/lb. 198.10
Wholesale beef exports, cents/lb. 237.48
Slaughter cattle, cents/lb. (live weight) 148.12
Feeder cattle, cents/lb. 202.92
Pork
Retail pork, cents/lb. 385.25
Wholesale pork, cents/lb. 78.96
Wholesale pork imports, cents/lb. 149.13
Wholesale pork exports, cents/lb. 78.96
Slaughter hogs, cents/lb. (live weight) 50.23
Lamb
Retail domestic lamb, cents/lb. 769.61
Retail imported lamb, cents/lb. 955.67
Wholesale lamb, cents/lb. 346.70
Slaughter lamb, cents/lb. (live weight) 144.00
Feeder lamb, cents/lb. 192.38
Poultry
Retail poultry, cents/lb. 189.73
Wholesale poultry, cents/lb. 93.64
Wholesale poultry exports, cents/lb. 93.64
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